Elliott strikes Dexcom board settlement after taking stake

Activist investor Elliott Investment Management has taken a stake in medical device firm Dexcom Inc. and struck a settlement ...
The Motley Fool

DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?

DexCom stock crashed after the company reported disappointing Q2 results and cut its full-year guidance. This performance raised questions about the potential impact of GLP-1 drugs on DexCom's ...
FierceBiotech

Dexcom receives FDA warning letter over CGM manufacturing issues

Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous glucose monitor maker’s facilities last year. In a filing with the SEC, ...
Medscape

Dexcom Issues Recall for G7, ONE+ Apps for Software Issues

Dexcom, Inc, has issued a recall for G7 Apps and ONE+ Apps because of a software design error failing to alert users of unexpected sensor failures. This recall ...
Barron's

DexCom Stock Plunges 40% After Earnings. GLP-1s Weren’t the Problem.

DexCom reported a sales miss in the second quarter. (Courtesy DexCom) Shares of DexCom were spiraling after the medical device company surprised Wall Street with a steep cut to guidance, and grim news ...
Reuters

Dexcom shares extend fall over 2026 growth concerns

Oct 31 (Reuters) - Dexcom (DXCM.O), opens new tab shares tumbled 12.8% on Friday after executives signaled that the medical device maker's 2026 growth forecast could fall short of Wall Street ...
Forbes

Will DexCom Stock Rebound To Its 2021 Highs Of $160?

DexCom stock (NASDAQ: DXCM) currently trades at $73 per share, around 55% below the highs of $163 seen in November 2021. In comparison, Insulet stock (NASDAQ: PODD) saw its stock decline 39% over the ...